Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
New strategic role will further enhance operational performance of all API and Formulated Product manufacturing services, focussing on industry leading product delivery across the Aesica Group
read more
Tuesday, February 18, 2014
Aesica, the global pharmaceutical contract development and manufacturing organisation (CDMO), has today announced the appointment of Ian Muir to the newly created position of Commercial Managing Director, effective from 24th February. The position is...
read more
Friday, February 15, 2013
Aesica, the global contract manufacturing organisation (CMO), announces that it will be joining Britest in a collaboration where members share knowledge and risk in defining innovative solutions to key manufacturing challenges.
read more
Aesica has recruited a Technical Director to create global Lead Technical Centres for API development, drug product development and technology innovation.
read more
Wednesday, November 25, 2020
Aeterna Zentaris has entered into an amendment of its existing License Agreement with NNBL related to the development and commercialization of macimorelin.
read more
Thursday, December 17, 2020
Aeterna Zentaris has entered into a licensing agreement with Consilient Health for the commercialization in Europe and the United Kingdom of macimorelin.
read more
AGC Chemicals now offers small-molecule API contract manufacturing services.
read more
AGC has announced the completion of its acquisition of Spain's synthetic pharmaceutical active ingredient manufacturer, Malgrat Pharma Chemicals, S.L.U. (MPC).
read more
Wednesday, November 15, 2017
Agenus announced the receipt of a $4 million payment for the advancement of an undisclosed antibody under the license and research collaboration agreement with Merck.
read more
Agilent Technologies Inc. announced it is investing approximately $725 million to double manufacturing capacity of therapeutic nucleic acids in response to rapid growth of the $1 billion market and strong demand for the company’s high-quality active ...
read more
Wednesday, January 10, 2018
Aimmune Therapeutics announced an expansion and extension of its exclusive supply agreement with Golden Peanut and Tree Nuts, to support AR101.
read more
Ajinomoto Bio-Pharma Services has announced the launch of AJILITY™, a flexible and agile drug product manufacturing platform.
read more
Thursday, August 29, 2019
Ajinomoto Bio-Pharma Services announced its intention to purchase the remaining 50 percent ownership interest in its Visakhapatnam, India joint venture, Granules OmniChem.
read more
Wednesday, November 20, 2019
Akcea and Ionis announced the closing of the exclusive licensing agreement with Pfizer for AKCEA-ANGPTL3-LRx.
read more
Akers Biosciences has acquired a licensing agreement with Premas Biotech, under which Akers will in-license a novel coronavirus vaccine candidate under development by Premas.
read more